Protein profile

PA5013

branched-chain amino acid aminotransferase

Genome: NC_002516.2

Gene: PA5013 ilvE Structure source: Experimental + AlphaFold UniProt O86428
Amino acids 307
Annotations 12
Features 17
PDB binders 11
Druggability 0.357

Overview

Basic information about this protein and its source genome.

Accession
PA5013
Gene
PA5013 ilvE
Status
annotated
Amino acids
307
Structure source
Experimental + AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
25.984
Human E-value
5.64e-12
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.357
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 11 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

11
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0004084 Catalysis of the reaction: a branched-chain amino acid (L-leucine, L-isoleucine and L-valine) + 2-oxoglutarate = L-glutamate + a 2-oxocarboxylate derived from the branched-chain amino acid.
  • GO:0052656 Catalysis of the reaction: L-isoleucine + 2-oxoglutarate = (S)-3-methyl-2-oxopentanoate + L-glutamate.
  • GO:0052654 Catalysis of the reaction:L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate.
  • GO:0052655 Catalysis of the reaction: L-valine + 2-oxoglutarate = 3-methyl-2-oxobutanoate + L-glutamate.
  • GO:0006532 The chemical reactions and pathways resulting in the formation of aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid.
  • GO:0009097 OBSOLETE. The chemical reactions and pathways resulting in the formation of isoleucine, (2R*,3R*)-2-amino-3-methylpentanoic acid.
  • GO:0009098 The chemical reactions and pathways resulting in the formation of L-leucine, 2-amino-4-methylpentanoic acid.
  • GO:0009099 The chemical reactions and pathways resulting in the formation of valine, 2-amino-3-methylbutanoic acid.
  • GO:0003824 Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
  • GO:0009081 The chemical reactions and pathways involving amino acids containing a branched carbon skeleton, comprising isoleucine, leucine and valine.

Sequence Features

Domain/signature hits from InterPro and related databases.

17 records
Show feature table
Start End DB Term Name
23 294 CDD cd01557 BCAT_beta_family
23 294 InterPro IPR033939 Branched-chain aminotransferase
11 127 FunFam G3DSA:3.30.470.10:FF:000001 Branched-chain-amino-acid aminotransferase
8 295 PANTHER PTHR42743 AMINO-ACID AMINOTRANSFERASE
11 306 NCBIfam TIGR01122 branched-chain-amino-acid transaminase
11 306 InterPro IPR005785 Branched-chain amino acid aminotransferase I
134 295 Gene3D G3DSA:3.20.10.10 -
134 295 InterPro IPR043132 Branched-chain-amino-acid aminotransferase-like, C-terminal
36 267 Pfam PF01063 Amino-transferase class IV
36 267 InterPro IPR001544 Aminotransferase class IV
194 222 ProSitePatterns PS00770 Aminotransferases class-IV signature.
194 222 InterPro IPR018300 Aminotransferase, class IV, conserved site
1 303 SUPERFAMILY SSF56752 D-aminoacid aminotransferase-like PLP-dependent enzymes
1 303 InterPro IPR036038 Aminotransferase-like, PLP-dependent enzymes
138 288 FunFam G3DSA:3.20.10.10:FF:000001 Branched-chain-amino-acid aminotransferase
4 133 Gene3D G3DSA:3.30.470.10 -
4 133 InterPro IPR043131 Branched-chain-amino-acid aminotransferase-like, N-terminal

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

1 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
PDB 6NST
X-ray 2.14 Å A,B,C,D,E,F
100.0% 1-307
Viewing
AlphaFold PA5013
AlphaFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
2 0.357

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 17.54 0.804
2 12.92 0.668
3 3.45 0.125
4 1.92 0.039
5 1.68 0.028

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

50 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
2ML P0AB80 145.2 Da LogP 0.83 TPSA 63.3 ✓ Ro5 ✓ Clean CC(C)C[C@@](C)(C(=O)O)N
4MV P0AB80 116.2 Da LogP 1.51 TPSA 37.3 ✓ Ro5 ✓ Clean CC(C)CCC(=O)O
AKG A0A0A7GJ30 146.1 Da LogP -0.50 TPSA 91.7 ✓ Ro5 ✓ Clean C(CC(=O)O)C(=O)C(=O)O
GBN Q5SM19 171.2 Da LogP 1.37 TPSA 63.3 ✓ Ro5 ✓ Clean C1CCC(CC1)(CC(=O)O)CN
GUA P0AB80 132.1 Da LogP 0.33 TPSA 74.6 ✓ Ro5 ✓ Clean C(CC(=O)O)CC(=O)O
PGU P0AB80 378.3 Da LogP 0.11 TPSA 186.5 1 viol. ✓ Clean Cc1c(c(c(cn1)COP(=O)(O)O)CN[C@@H](CCC(=O)O)C(=O…
PMP Q5SM19 248.2 Da LogP 0.16 TPSA 125.9 ✓ Ro5 ✓ Clean Cc1c(c(c(cn1)COP(=O)(O)O)CN)O
PPE Q5SM19 379.3 Da LogP -0.47 TPSA 187.8 1 viol. ✓ Clean Cc1c(c(c(c[nH+]1)COP(=O)(O)O)CN[C@@H](CCC(=O)O)…
PXG O29329 368.3 Da LogP 2.02 TPSA 149.2 ✓ Ro5 ✓ Clean Cc1c(c(c(cn1)COP(=O)(O)O)CNc2cccc(c2)C(=O)O)O
PY5 F2L0W0 348.3 Da LogP 1.05 TPSA 149.2 ✓ Ro5 ✓ Clean CCC[C@@H](C(=O)O)NCc1c(cnc(c1O)C)COP(=O)(O)O
TAM O29329 163.2 Da LogP -1.17 TPSA 86.7 ✓ Ro5 ✓ Clean C(CO)C(CCO)(CCO)N

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.